Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice-Reference-Cited by-同舟云学术

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

Published:2016-04 Issue:16 Volume:34 Page:1927-1935
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bengtsson Karin Lövgren,Song Haifeng,Stertman Linda,Liu Ye,Flyer David C.,Massare Michael J.,Xu Ren-Huan,Zhou Bin,Lu Hanxin,Kwilas Steve A.,Hahn Timothy J.,Kpamegan Eloi,Hooper Jay,Carrion Ricardo,Glenn Gregory,Smith Gale

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference46 articles.

1. A race for an Ebola vaccine: promises and obstacles;Cooper;Trends Microbiol,2015

2. Ebola virus vaccines: an overview of current approaches;Marzi;Expert Rev Vaccines,2014

3. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants;Radosević;Vaccine,2008

4. Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice;Madhun;Vaccine,2009

5. Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial;Cox;Vaccine,2011

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges;ACS Nano;2024-08-26

2. SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma;Vaccines;2024-06-19

3. Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines;Antiviral Research;2024-05

4. Vaccine adjuvants for infectious disease in the clinic;Bioengineering & Translational Medicine;2024-03-22

5. Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors;Human Vaccines & Immunotherapeutics;2024-03-04